CVC1302佐剂增强灭活O型口蹄疫疫苗小鼠免疫应答机制
该研究在小鼠中探讨CVC1302佐剂增强灭活O型口蹄疫病毒(FMDV)疫苗免疫应答的局部机制。CVC1302佐剂疫苗(KV-CVC1302)可诱导肌肉组织分泌MCP-1、MIP-1α和MIP-1β趋化因子,并显著增加注射部位单核细胞募集;引流淋巴结蛋白质组学鉴定出35个差异表达蛋白,涉及信号转导、凋亡、内吞和先天免疫应答,AMPK、磷脂酶D、cAMP、Rap1和MAPK信号通路可能被诱导。
要点
- CVC1302佐剂可增强灭活FMDV疫苗在小鼠中的局部免疫应答。
- KV-CVC1302诱导肌肉分泌MCP-1、MIP-1α和MIP-1β并增加单核细胞募集。
- 引流淋巴结中35个蛋白差异表达,涉及多条免疫相关信号通路。
核心结论
- CVC1302佐剂通过诱导趋化因子分泌和单核细胞募集增强灭活FMDV疫苗的局部免疫应答,并调节引流淋巴结中多种信号通路。
研究设计与样本
- 小鼠模型研究,比较KV-CVC1302与单独灭活FMDV(KV)免疫后局部注射部位和引流淋巴结的免疫应答。
- 采用iTAQ定量蛋白质组学分析免疫后10天引流淋巴结的差异表达蛋白。
主要发现
- KV-CVC1302免疫小鼠肌肉组织分泌MCP-1、MIP-1α和MIP-1β趋化因子。
- KV-CVC1302免疫小鼠注射部位募集单核细胞数量显著高于KV免疫小鼠。
- 免疫后10天,对照组、KV组和KV-CVC1302组间鉴定出35个差异表达蛋白,主要参与信号转导、凋亡、内吞和先天免疫应答。
- 通路分析提示AMPK、磷脂酶D、cAMP、Rap1和MAPK信号通路可能被CVC1302诱导。
临床怎么用
- 该机制研究为CVC1302佐剂在FMDV疫苗中的应用提供实验室依据,尚未涉及人体应用或临床推荐。
局限性
- 研究仅在小鼠中进行,结论外推到其他物种需进一步验证。
- 机制发现基于关联性分析,未进行功能验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The adjuvant CVC1302 was previously shown to efficiently enhance the immunogenicity of killed foot-and-mouth disease virus (FMDV) in mice and piglets. However, the underlining mechanism of action of CVC1302 remains unclear, especially at local injection sites and draining lymph nodes. Since the FMDV vaccine is administrated intramuscularly in field settings, we studied local immune responses to FMDV following intramuscular injection in mice, and found that CVC1302-adjuvanted killed FMDV (KV-CVC1302) induced secretion of several chemokines in murine muscle tissues, including MCP-1, MIP-1α, and MIP-1β. The number of monocytes recruited to the site of injection was significantly higher in mice immunized with KV-CVC1302 compared with mice immunized with killed FMDV alone (KV). iTAQ-based quantitative proteomic assays were additionally employed to explore the molecular mechanisms of CVC1302 action in the draining lymph nodes. A total of 35 proteins were identified as being differentially expressed among the control group, KV-immunized group and KV-CVC1302-immunized group at 10 days post immunization (dpi). Proteins exhibiting differential expression were mainly involved in signal transduction, apoptosis, endocytosis and innate immune responses. Pathway analysis demonstrated that AMPK, phospholipase D, cAMP, Rap1, and MAPK signaling pathways were potentially induced by the immunopotentiator CVC1302. Understanding the local mechanism of CVC1302 action at injection sites and draining lymph nodes will provide new insights into the development of FMDV vaccines.
引用
- Du L, Yu X, Hou L, et al. Identification of mechanisms conferring an enhanced immune response in mice induced by CVC1302-adjuvanted killed serotype O foot-and-mouth virus vaccine. Vaccine. 2019. PMID: 31526618. doi:10.1016/j.vaccine.2019.09.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。